SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-062079
Filing Date
2021-05-06
Accepted
2021-05-06 08:35:44
Documents
14
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114804d1_8k.htm   iXBRL 8-K 24044
2 EXHIBIT 99.1 tm2114804d1_ex99-1.htm EX-99.1 76251
6 GRAPHIC tm2114804d1_ex99-1img001.jpg GRAPHIC 17813
  Complete submission text file 0001104659-21-062079.txt   311835

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA albo-20210506.xsd EX-101.SCH 3038
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20210506_lab.xml EX-101.LAB 34238
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20210506_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2114804d1_8k_htm.xml XML 3574
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 21895952
SIC: 2834 Pharmaceutical Preparations